Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin for Neurodevelopment in Preterm Infants
NCT03506841Phase 1Completed
- Sponsor
- Mansoura University Children Hospital
- Start
- Jun 2016
- Primary completion
- Jun 2019
- Modality
- Native Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cerebrolysin in preterm birth (2 arms), sponsored by Mansoura University Children Hospital. Primary endpoint: Neurodevelopmental outcome (Denver Scale II) at 12 months. Started Jun 2016; status: completed.
02
Drugs
cerebrolysin
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT03506841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03506841.